Home > Income Statement > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Revenue

    Back to Income Statement
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹398 Cr₹215 Cr₹353 Cr₹14 Cr₹14 Cr

What is the latest Revenue of SENORES PHARMACEUTICALS ?

The latest Revenue ratio of SENORES PHARMACEUTICALS is ₹398 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹398 Cr
Mar2025₹215 Cr
Mar2024₹353 Cr
Mar2023₹14 Cr
Mar2022₹14 Cr

How is Revenue of SENORES PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹398 Cr
85.65
Mar2025 ₹215 Cr
-39.29
Mar2024 ₹353 Cr
2,393.79
Mar2023 ₹14 Cr
0.00
Mar2022 ₹14 Cr -

Compare Revenue of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹5,034.8 Cr -5.5% -9.2% 40.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

-5.5%

-9.2%

40.2%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses